Daniele Pastori

Pubblicazioni

Titolo Pubblicato in Anno
How to treat patients with splanchnic vein thrombosis: recent advances POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ 2023
C-reactive protein levels are associated with early cardiac complications or death in patients with acute ischemic stroke: a propensity-matched analysis of a global federated health from the TriNetX network INTERNAL AND EMERGENCY MEDICINE 2023
Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments CURRENT PROBLEMS IN CARDIOLOGY 2023
Association of proprotein convertase subtilisin/kexin type 9 (PCSK9) levels with abnormally high ankle-brachial index in atrial fibrillation KARDIOLOGIA POLSKA 2023
Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation FRONTIERS IN PHARMACOLOGY 2023
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2023
Aging and Antithrombotic Treatment ANTIOXIDANTS & REDOX SIGNALING 2023
Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry EUROPEAN JOURNAL OF INTERNAL MEDICINE 2023
Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study THROMBOSIS RESEARCH 2023
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review AUTOIMMUNITY REVIEWS 2023
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2023
Factor V Leiden, prothrombin, MTHFR, and PAI-1 gene polymorphisms in patients with arterial disease: A comprehensive systematic-review and meta-analysis THROMBOSIS RESEARCH 2023
Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis JOURNAL OF THROMBOSIS AND HAEMOSTASIS 2023
Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium? AMERICAN HEART JOURNAL 2023
Venous Thromboembolism in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of 4,170,027 Patients 2023
Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation. impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients THROMBOSIS AND HAEMOSTASIS 2022
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2022
Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study THROMBOSIS RESEARCH 2022
Plasma homocysteine in Behcet's disease: a systematic review and meta-analysis THROMBOSIS AND HAEMOSTASIS 2022

ERC

  • LS4
  • LS4_10
  • LS7
  • LS7_10

Keywords

cardiovascular disease
anticoagulation
Novel oral anticoagulants
atrial fibrillation
atherosclerosis
NAFLD
NASH
antiphospholipid antibody syndrome
ischemic heart disease
cardiovascular risk
Thrombosis
Atherothrombosis

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma